I’m excited regarding the Herr-Vaxx announcement.
The gurus at Imugene are so ‘forward thinking’.
Having achieved some amazing results in trials so far on patients who have not previously fared well from other treatment, and who are gravely ill, it is pleasing to read that more recently diagnosed cancer patients will also be trialled on Herr-Vaxx combos.
If early treatment proves successful, on patients who have not been weakened from chemo or disease progression, it would be (to use LC’s expression) a paradigm shift in the way in which cancer patients are treated.
Go Imugene. So impressive!
PDS
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-284
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.002(2.90%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.7¢ | $1.445M | 21.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 2363454 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 14705 | 1 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.002 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.7¢ | 9797879 | ||
| Last updated 16.01pm 22/05/2024 ? | |||||
| IMU (ASX) Chart |